Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Linagliptin Therapy on Myocardial Diastolic Function in Patients With Type 2 Diabetes Mellitus

NCT01888796 is registered in ClinicalTrials.gov with RWTH Aachen University as lead sponsor.

NCT NCT01888796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01888796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Linagliptin Therapy on Myocardial Diastolic Function in Patients With Type 2 Diabetes Mellitus
Lead sponsor
RWTH Aachen University
Phase
Phase 3
Overall status
Terminated
Start date
September 30, 2013
Completion date
December 31, 2014
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus type 2 (t2dm), left ventricular diastolic dysfunction